|Posted by firstname.lastname@example.org on October 21, 2017 at 6:35 PM||comments (2)|
Have completed the Certolizumab pegol study and have good results. Waiting to get the study published and start a multi-center larger study.
|Posted by email@example.com on March 23, 2016 at 6:30 PM||comments (2)|
There is presently 21 patients entered in the Cimzia to Treat Interstitial Cystitis Study. Patients are getting better and no one has had a problem. Cimzia is a drug that is FDA approved to treat other autoimmune diseases. There is basic scientific research that demonstrates that Cimzia should improve the symptoms of patients with Interstitial Cystitis. Females between the age of 18 and 65 who have not responded to other treatments for Interstitial Cystitis are eligible for this study. Contac...Read Full Post »
|Posted by firstname.lastname@example.org on January 23, 2016 at 7:00 PM||comments (0)|
I have received FDA approval for all my IC studies and am presently the principal investigator in three research studies available for the treatment of interstitial cystitis. One is with Dr. Parsons from UCSD on a better bladder instillation treatment. The next is a study on the benefits of patient counseling and an FDA approved medicine that treats autoimmune diseases. This is the certolizumab pegol study and is the most promising. The last is a study with Allergan ...Read Full Post »
|Posted by email@example.com on August 20, 2015 at 9:15 PM||comments (0)|
The treatment and clinical research of interstitial cystitis is going well. I see 20-30 IC patients every day. I am currently running five clinical research studies on the evaluation and treatment of interstitial cystitis. If you are interested, please contact my office.
|Posted by firstname.lastname@example.org on January 24, 2015 at 9:05 AM||comments (0)|